West Introduces Analytical Services for Pulmonary and Nasal Devices

West Analytical Services LLC has introduced a testing platform to help clients mitigate the risks associated with testing pulmonary and nasal drug products and their delivery devices.

“Moving pulmonary and nasal drug products from early-stage development to the market is challenging for pharmaceutical, biopharmaceutical and medical device companies,” said Fran DeGrazio, Vice President, Marketing and Strategic Business Development. “The challenges include testing the drug product and delivery device. Companies may not have a proven device selection process in place and may not have validated laboratory methods or instruments required to test the drug product and the device. Any misstep along the way runs the risk of costly project delays.”

“We can help clients move their pulmonary and nasal drug products to market without undue delay by applying our knowledge and experience in pharmaceutical packaging, drug product development and regulatory guidances to provide clients with proven analytical laboratory support,” said Ms. DeGrazio.

West’s analytical services for pulmonary and nasal drug products encompass early-stage development, clinical development and post-product launch stages for pharmaceutical, biotechnology and medical device clients.

West’s laboratory professionals understand the unique requirements of pulmonary and nasal products and delivery devices and provide testing for:

· Metered Dose Inhalers (MDIs)

· Dry Powder Inhalers (DPIs)

· Nasal and Oral Sprays

· Nebulizers

The nasal and pulmonary product testing will be conducted at West’s FDA-registered, cGMP-compliant laboratory in Lionville, Pa.

About West Analytical Services

West Analytical Services LLC (WestAnalyticalServices.com) applies pharmaceutical industry expertise to support clients through the complex laboratory analysis associated with meeting drug product, container closure and packaging regulatory guidelines. West’s laboratories are fully qualified to provide testing for drug product, devices, administration systems and components. The laboratories, located in Lionville, Pa., and Maumee, Ohio, are FDA-registered and GMP-compliant. West’s laboratory professionals provide analytical testing for drug products as well as their packaging, device or administration system for pharmaceutical, biotechnology and medical device clients. The laboratory team works closely with clients to ensure that analytical testing meets appropriate guidelines and global agency requirements.

West Analytical Services’ parent company, West Pharmaceutical Services, Inc., Lionville, Pa., is the world’s premier manufacturer of components and systems for improving the safety and effectiveness of therapeutic and diagnostic health care delivery systems.

Contact information:

Phone: 800-345-9800, option 5 Email: WestAnalyticalServices@westpharma.com Web site: WestAnalyticalServices.com